Tower Research Capital (TRC)’s MEDIROM Healthcare Technologies MRM Stock Holding History

Tower Research Capital (TRC)’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,377	Closed	-$7.16K	–	5429
2025 Q3	$7.16K	Buy	3,377 +3,366	+30,600%	+$5.65K	﹤0.01%	4113
2025 Q2	$16	Buy	+11	New	+$12	﹤0.01%	5225
2023 Q4	–	Sell	-6	Closed	-$34	–	6081
2023 Q3	$34	Buy	+6	New	+$35	﹤0.01%	5804
2022 Q1	–	Sell	-189	Closed	-$1K	–	6387
2021 Q4	$1K	Sell	189 -395	-68%	-$2.88K	﹤0.01%	5855
2021 Q3	$5K	Buy	+584	New	+$4.43K	﹤0.01%	4870

Other funds holding MRM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MRM Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of MEDIROM Healthcare Technologies (MRM) in Q4 2025, closing a stake of 3,377 shares — an estimated $7.16K sold.

Tower Research Capital (TRC) first reported a position in MRM in Q3 2021 and held it in 5 quarters. The position peaked at $7.16K in Q3 2025. 3 funds tracked by Wall St. Rank hold MRM as of Q4 2025.

Tower Research Capital (TRC) reported no remaining MEDIROM Healthcare Technologies position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,377 MEDIROM Healthcare Technologies shares in Q4 2025, an estimated $7.16K.
Tower Research Capital (TRC) first reported a position in MEDIROM Healthcare Technologies in Q3 2021 and held it in 5 quarters.
Tower Research Capital (TRC)'s MEDIROM Healthcare Technologies position peaked at $7.16K in Q3 2025.
3 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.